News

Samsung Biologics and Vir Biotechnology to co-manufacture SARS-COV-2 antibodies

Under the deal valued at approximately$362 million, Samsung Biologics is expected to commence its manufacturing as early as October with the first engineering run.

Apr 13, 2020

By : Team ABLE

Monumental Blunder to ask free COVID-19 testing by private labs

“Dr P M Murali, President of ABLE (Association of Biotechnology Led Enterprises) from 2012-18 and current Executive Council Member and a biotech industry veteran explains the economics behind the testing for COVID-19 and how a forced free testing by private labs will make the sector unviable in this special column written for eN-ABLE.”

Apr 11, 2020

By : Team ABLE

HiMedia supports in Coronavirus Endemic with HIVIRALTM VIRAL TRANSPORT SYSTEMS (VTM)

HiMedia, with its core expertise in media development with 45 years of experience has successfully developed the ideal VTM decades ago. 

Apr 11, 2020

By : Team ABLE

Here’s how India can become a global bio-medical hub post Covid-19: Kiran Mazumdar Shaw

Indian start-ups are thinking creatively and using cutting-edge technology. But many of them are stuck at the stage of taking ‘ideas’ to ‘proof of concept’.

Apr 10, 2020

By : The Print

Mylan updates efforts regarding COVID-19; hydroxychloroquine sulfate tablets production volume increased

Mylan's hydroxychloroquine sulfate tablets are currently approved by the FDA for the treatment of malaria, lupus erythematosus and rheumatoid arthritis.

Apr 09, 2020

By : Team ABLE